Atlas Arteria Limited (ASX:ALX)
Australia · Delayed Price · Currency is AUD | Market Cap | 6.96B -4.9% |
| Revenue (ttm) | 160.00M +9.7% |
| Net Income | 259.50M -22.7% |
| EPS | 0.18 -22.6% |
| Shares Out | 1.45B |
| PE Ratio | 26.84 |
| Forward PE | 17.77 |
| Dividend | 0.40 (8.33%) |
| Ex-Dividend Date | Mar 25, 2026 |
| Volume | 1,505,152 |
| Average Volume | 3,687,241 |
| Open | 4.780 |
| Previous Close | 4.800 |
| Day's Range | 4.780 - 4.820 |
| 52-Week Range | 4.200 - 5.540 |
| Beta | 0.53 |
| RSI | 64.43 |
| Earnings Date | Aug 27, 2026 |
About Atlas Arteria
Atlas Arteria Limited owns, develops, and operates toll roads in France, Germany, Australia, Bermuda, and the United States. It holds 30.82% interest in the APRR motorway network, 30.85% interest in the ADELAC commuter road, and 30.79% interest in the A79 transversal link located in France; 100% interest in the Warnow Tunnel located in Rostock, Germany; 66.67% interest in the Chicago Skyway situated in Chicago, United States; and 100% interest in the Dulles Greenway located in Virginia, United States. Atlas Arteria Limited was formerly known as... [Read more]
Financial Performance
In 2025, Atlas Arteria's revenue was 160.00 million, an increase of 9.66% compared to the previous year's 145.90 million. Earnings were 259.50 million, a decrease of -22.74%.
Financial StatementsNews
Australia's Atlas Arteria logs best day since June 2022 on $4.9 billion buyout offer
Atlas Arteria shares rose more than 13% on Monday after IFM Global Infrastructure Fund offered to acquire all the shares it does not currently own in the Australian toll operator, valuing it at A$6.8...
Atlas Arteria Earnings Call Transcript: H2 2025
Proportional toll revenue and EBITDA grew over 9% year-over-year, supported by traffic growth and CPI-linked toll increases, while free cash flow per security dipped due to the French TST. Distribution remains stable at AUD 0.40 per security, with the same guidance for 2026.
Atlas Arteria Earnings Call Transcript: H1 2025
Proportional toll revenue and EBITDA rose 8% year-over-year, while net profit fell 33% due to a one-time French tax. Distribution guidance of $0.40 per security for 2025 is maintained, with strong free cash flow and no plans for new equity issuance.
Atlas Arteria Transcript: AGM 2025
The AGM highlighted strong toll revenue growth, a new distribution policy, and ongoing legal and regulatory challenges in France and the U.S. Board renewal, enhanced governance, and sustainability initiatives were emphasized, with all resolutions supported by major shareholders.
Atlas Arteria Earnings Call Transcript: H2 2024
2024 saw solid revenue and cash flow growth, with proportional toll revenue up 5.1% and net profit after tax up 7.4% year-over-year. Distribution guidance is set at AUD 0.40 per security for 2025, despite regulatory and tax challenges in France and the U.S.
Atlas Arteria Earnings Call Transcript: Q2 2024
Proportionate toll revenue grew strongly in H1 2024, driven by inflation-linked increases, while new French tax and cost escalation impacted APRR earnings. Distribution guidance of AUD 0.40 per security was reaffirmed, with robust free cash flow and capital management initiatives supporting future payouts.
Atlas Arteria Transcript: AGM 2024
Atlas Arteria Earnings Call Transcript: H2 2023
Atlas Arteria upgraded to Buy from Hold at Jefferies
Jefferies upgraded Atlas Arteria to Buy from Hold with a price target of A$6.88, up from A$6.77, following the company’s report of first half results. While the results “will do